Asymmetric dimethylarginine: understanding the physiology, genetics, and clinical relevance of this novel biomarker. Proceedings of the 4th International Symposium on ADMA.

@article{Boeger2009AsymmetricDU,
  title={Asymmetric dimethylarginine: understanding the physiology, genetics, and clinical relevance of this novel biomarker. Proceedings of the 4th International Symposium on ADMA.},
  author={Rainer H. Boeger},
  journal={Pharmacological research},
  year={2009},
  volume={60 6},
  pages={447}
}
It has been 6 years since the first International Meeting on ADMA ook place, in October 2002, in Hamburg, Germany. What was a ery small group of scientists who were interested in this widely nknown – and largely ill understood – molecule at that time, has ecome an international group of more than 150 scientists from round the world who spent two exciting days of sharing data and timulating research in Bregenz, Austria, from August 28–30, 2008. ince its first description as an endogenous… CONTINUE READING

From This Paper

Topics from this paper.
2 Citations
0 References
Similar Papers